Table 2. Outcome Measures.
| Outcome Measure | Standard | Mnemonic | Standard vs Mnemoni Between Group Comparison | |||
|---|---|---|---|---|---|---|
| Immediately post-counseling 2 Months | Immediately post-counseling 2 Months | P value | ||||
| N=47 | N=41 | N=43 | N=40 | Baseline 2 Months | ||
|
| ||||||
| * QQPPI (mean, 95% CI) | 62.2 [59.1, 65.3] | 66.4, [64.3,68.4] | 0.03 | Not applicable | ||
|
| ||||||
| MHQ(Median[Q1,Q3]) | Wilcoxan Rank sum | |||||
| Incontinence Impact | 50 [50,75] | 50 [25,75] | 75 [50,75] | 50 [50,75] | 0.09 | 0.56 |
| Role Limitations | 25 [0,50] | 25 [0,50] | 38 [13,50] | 20 [6,50] | 0.06 | 0.008 |
| Physical Limitation | 25 [0,50] | 50 [0,75] | 50 [0,75] | 50 [0,50] | 0.17 | 0.04 |
| Social Limitation | 8 [0,50] | 17 [0,33] | 17 [0,50] | 17 [0,46] | 0.56 | 0.40 |
| Personal Relationships | 0 [0,50] | 0 [0,50] | 0 [0,50] | 0 [0,50] | 0.36 | 0.18 |
| Emotions | 29 [0,58] | 33 [8,67] | 42 [17,67] | 29 [17,54] | 0.13 | 0.03 |
| Sleep | 0 [0,38] | 25 [0,38] | 25 [0,63] | 13 [0,50] | 0.053 | 0.045 |
| Severity | 45 [25,65] | 50 [30,76] | 50 [35,65] | 45 [25,65] | 0.14 | 0.1 |
| Overall Score | 29[16,43] | 27[16,52] | 40 [24,52] | 31 [17,56] | 0.14 | 0.02 |
|
| ||||||
| FISI (mean, 95% CI) | 34.1[31.0, 37.1] | 27.2 [24.0,30.5] | 32.4, [28.8,36.0] | 28.0, [23.6, 32.3] | 0.47 | 0.2 t-test |
|
| ||||||
| Treatment recall (mean 95% CI) | 1.7, [1.4, 2.1] | 1.8, [1.4,2.1] | 3.4[2.8,4. 1] | 2.3 [1.7, 2.8] | <0.01 | 0.08 t-test |
*
Bold face type indicates significant (p<0.05) difference.